SING GEORGE L

CIK 00012254711 companyTARRYTOWN, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001225471

Recent Transactions

50 trades

Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2026-01-02+1,962→ 1,962 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2026-01-02+155→ 31,007 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-12-30$774.03/sh−6,188→ 30,852 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-12-30$520.01/sh+9,212→ 37,040 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-12-30−9,212→ 0 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-01-02+166→ 27,828 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-01-02+1,958→ 1,958 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-12-31−3,338→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-12-31$413.33/sh+3,338→ 29,610 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-12-31$708.19/sh−1,948→ 27,662 total
Gift
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-09-04−1,200→ 26,272 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-05-03$413.33/sh+2,000→ 28,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-05-03−2,000→ 3,338 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-05-03$942.53/sh−877→ 27,472 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$990.00/sh−500→ 26,349 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$995.00/sh−500→ 26,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$413.33/sh+500→ 26,849 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$413.33/sh+500→ 26,849 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-26−1,000→ 5,338 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-23−500→ 6,338 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-23$413.33/sh+500→ 26,849 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-23$985.00/sh−500→ 26,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-22$413.33/sh+1,000→ 27,349 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-22$960.00/sh−1,000→ 26,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-22−3,000→ 6,838 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-22$970.00/sh−1,000→ 26,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-22$413.33/sh+1,000→ 27,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-22$413.33/sh+1,000→ 27,349 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-22$965.00/sh−1,000→ 26,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-09−500→ 9,838 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-09$955.00/sh−500→ 26,349 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-09$413.33/sh+500→ 26,849 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-08−500→ 10,338 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-08$413.33/sh+500→ 26,849 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-08$945.00/sh−500→ 26,349 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-02+1,607→ 1,607 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02+135→ 26,349 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-01-03+165→ 26,214 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-01-03+1,929→ 1,929 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-02-28$614.00/sh−1,000→ 27,049 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-02-28$617.00/sh−1,000→ 26,049 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-02-25$621.00/sh−2,000→ 28,049 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2022-01-03+191→ 30,049 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2022-01-03+2,707→ 2,707 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2021-11-22$655.00/sh−1,000→ 30,858 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2021-11-22$660.00/sh−1,000→ 29,858 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2021-11-19$655.00/sh−1,000→ 31,858 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2021-11-18$650.00/sh−4,000→ 32,858 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2021-11-16$660.00/sh−2,000→ 36,858 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2021-11-16$658.79/sh−2,000→ 38,858 total

Companies

REGENERON PHARMACEUTICALS, INC.
Director
$REGN

Recent Filings

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591

View on SEC.gov